Obesity and Asthma:a Specific Phenotype

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-09-30

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Clinicians frequently observed that obese women referred for severe asthma do not respond to treatment. These patients, despite the presence of wheezing, often have normal expiratory flows and normal or "borderline" airway responsiveness.

It is therefore possible that this mode of presentation reflect a pseudo-asthmatic state for which clinical definition and characteristics and optimal management remain to be determined.

The aim of this study was to study the pulmonary physiological and airway inflammatory characteristics and response to treatment of obese women considered to have clinically severe asthma in order to demonstrate that some of these patients have a phenotype that is not that of asthma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Physiology of the Asthma of the Obese Subjects. Breathing Obesity Asthma Study (BOA)

NCT00577733

Asthma Obesity

COMPLETED

Obesity-asthma Endophenotype and Diaphragm Mobility in Adolescence

NCT03029936

Obesity Asthma

COMPLETED

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

NCT03215836

Asthma Obesity Metabolic Syndrome

RECRUITING NA

Phenotyping Asthma for Bronchial Thermoplasty

NCT03435237

Severe Asthma

RECRUITING

Bronchial Asthma & Its Exacerbation

NCT06331897

Bronchial Asthma

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Twenty-five obese women (BMI over 30) and 25 non-obese women (18\>BMI\<25) considered to have severe asthma by their physician and requiring corticosteroids to control their asthma will have the following investigation:

* Respiratory questionnaires focussing on the nature and time-course of symptoms, asthma control criteria, medication use.
* Physical examination, including measures of BMI, waist, hips and ratio waist/hips
* Blood test for Complete Blood Count, blood glucose, total IgE levels and markers of systemic inflammation (C-Reactive Protein, fibrinogen…)
* Spirometry and bronchodilator response.
* Induced sputum analysis and Exhaled Breath Condensate pH to assess airway inflammation.
* Skin prick tests with a battery of common airborne allergens
* Measurement of lung volumes and airway resistance + MIP and MEP.
* Methacholine challenge (up to 16 mg/ml) with Borg scores for breathlessness and chest tightness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obese asthmatics

Obese subjects with asthma (on inhaled corticosteroids)

No interventions assigned to this group

Non obese asthmatics

Non obese subjects with asthma (on inhaled corticosteroids)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Will be women aged 18 years and over
* Will be in good health apart from asthma or obesity as determined by history and physical examination (No other condition that could influence the proposed tests).
* All will be non smokers or ex-smokers for more than six months with a smoking history of no more than 10 pack- years (i.e., one pack per day or its equivalent for 10 years.)
* Subjects will have a physician's made diagnosis of severe asthma and treated with corticosteroids.

Exclusion Criteria

* Subjects who are, in the opinion of the investigator, mentally or legally incapacitated thus preventing informed consent from being obtained.
* Subjects having a co-existing illness that precludes them from the trial.
* Pregnancy or lactation
* Contraindication to the prednisone treatment.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No